av/bone-therapeutics--big.svg

COM:BIOSENIC

BioSenic

  • Stock

Last Close

0.01

22/11 16:13

Market Cap

3.49M

Beta: -

Volume Today

856.04K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
average payables
1.13M
-
1.99M
77.13%
2.34M
17.10%
2.07M
11.26%
2.57M
23.88%
3.02M
17.82%
3.16M
4.31%
4.12M
30.57%
4.84M
17.39%
3.25M
32.89%
average receivables
book value per share
0.02
-
-2.80
13,658.26%
4.26
252.24%
2.23
47.73%
0.35
84.39%
0.59
69.61%
0.21
63.61%
0.28
32.10%
-101.90
36,027.38%
0.03
100.03%
capex per share
-0.58
-
-0.89
53.77%
-0.47
47.41%
-0.09
81.23%
-0.06
31.29%
-0.04
35.81%
-0.03
16.44%
-0.01
75.59%
-3.12
39,204.00%
-0.00
100.00%
capex to depreciation
-4.35
-
-8.15
87.32%
-7.87
3.47%
-1.12
85.70%
-0.79
29.59%
-0.51
35.56%
-0.41
19.33%
-0.15
62.41%
-1.11
619.20%
-0.08
92.51%
capex to operating cash flow
0.54
-
0.86
58.64%
0.26
69.29%
0.05
79.84%
0.04
29.10%
0.02
39.09%
0.03
29.92%
0.01
80.60%
0.02
180.00%
0.00
83.83%
capex to revenue
-10.12
-
-0.30
97.08%
-0.09
-
-0.21
122.58%
cash per share
0.80
-
3.42
327.24%
5.09
48.95%
2.96
41.81%
1.23
58.57%
1.07
12.54%
0.91
15.73%
1.25
38.06%
161.32
12,811.02%
0.02
99.99%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.43
-
0.78
80.31%
0.25
68.47%
0.32
30.32%
0.47
45.78%
0.50
6.44%
0.61
22.72%
0.60
2.71%
1.05
76.55%
0.71
32.46%
debt to equity
88.27
-
-2.00
102.26%
0.44
122.12%
0.81
83.97%
4.95
509.44%
2.86
42.22%
6.70
133.99%
4.45
33.54%
-3.07
169.08%
5.91
292.19%
dividend yield
earnings yield
-0.08
-
-0.11
26.59%
-0.11
3.88%
-0.24
121.53%
-0.23
5.06%
-0.42
79.51%
-0.30
27.52%
-0.39
30.19%
-292.32
74,523.35%
-0.18
99.94%
enterprise value
51.91M
-
61.54M
18.56%
107.45M
74.61%
45.43M
57.72%
58.53M
28.83%
38.93M
33.49%
39.85M
2.37%
30.63M
23.14%
11.33M
63.00%
30.52M
169.33%
enterprise value over ebitda
-14.96
-
-11.99
19.86%
-9.00
24.97%
-3.76
58.25%
-5.06
34.59%
-2.97
41.19%
-4.49
51.13%
-2.12
52.90%
-0.96
54.63%
-13.47
1,303.09%
ev to operating cash flow
-15.85
-
-17.46
10.15%
-9.13
47.70%
-4.00
56.25%
-5.31
32.93%
-3.02
43.20%
-3.83
26.99%
-1.90
50.29%
-0.89
53.46%
-15.98
1,702.66%
ev to sales
1.43K
-
38.93
97.27%
30.63
-
11.33
63.00%
free cash flow per share
-1.65
-
-1.93
16.88%
-2.25
16.46%
-1.75
22.39%
-1.67
4.51%
-1.73
3.89%
-1.12
35.25%
-1.38
22.88%
-195.68
14,082.33%
-0.02
99.99%
free cash flow yield
-0.10
-
-0.12
16.88%
-0.12
4.39%
-0.22
94.29%
-0.21
7.65%
-0.39
85.84%
-0.31
20.06%
-0.53
72.27%
-293.81
55,266.46%
-0.17
99.94%
graham net net
-3.38
-
-6.53
93.17%
1.72
126.39%
-0.44
125.54%
-2.10
376.92%
-1.72
18.08%
-1.23
28.60%
-0.59
52.33%
-238.40
40,628.39%
-0.20
99.91%
graham number
0.79
-
10.33
1,210.11%
14.34
38.80%
9.75
31.99%
3.82
60.86%
4.98
30.46%
2.30
53.78%
2.55
10.76%
668.10
26,105.99%
0.11
99.98%
income quality
0.81
-
0.63
22.65%
0.96
53.65%
0.89
7.71%
0.90
0.89%
1.13
25.55%
1.09
3.49%
0.92
15.12%
1.06
15.33%
0.82
22.49%
intangibles to total assets
0.00
-
0.00
53.24%
0.00
37.46%
0.00
5.98%
0.00
17.89%
0.00
28.32%
0.00
46.37%
0.00
9.83%
0.00
3.18%
0.65
55,878.24%
interest coverage
-22.97
-
-22.15
3.58%
-43.04
94.33%
-32.99
23.36%
-29.06
11.89%
-38.09
31.07%
-28.08
26.30%
-22.15
21.11%
-14.23
35.74%
-8.34
41.41%
interest debt per share
1.88
-
5.67
201.34%
1.93
66.02%
1.87
3.04%
1.78
4.47%
1.73
3.17%
1.48
14.39%
1.32
10.78%
326.00
24,596.54%
0.18
99.95%
inventory turnover
invested capital
88.27
-
-2.00
102.26%
0.44
122.12%
0.81
83.97%
4.95
509.44%
2.86
42.22%
6.70
133.99%
4.45
33.54%
-3.07
169.08%
5.91
292.19%
market cap
48.78M
-
54.17M
11.04%
128.63M
137.45%
53.32M
58.54%
55.14M
3.40%
34.25M
37.89%
34.77M
1.52%
30.48M
12.33%
44.22K
99.85%
11.53M
25,983.13%
net current asset value
-4.66M
-
-14.43M
209.55%
19.46M
234.91%
5.16M
73.51%
-8.18M
258.55%
-6.26M
23.40%
-8.61M
37.53%
-2.69M
68.73%
-12.25M
354.73%
-21.57M
76.17%
net debt to ebitda
-0.90
-
-1.44
59.56%
1.77
223.52%
0.65
63.21%
-0.29
144.90%
-0.36
21.99%
-0.57
60.34%
-0.01
98.20%
-0.96
9,189.31%
-8.38
776.33%
net income per share
-1.34
-
-1.69
26.59%
-2.14
26.54%
-1.90
11.52%
-1.86
1.82%
-1.87
0.35%
-1.10
41.29%
-1.02
7.13%
-194.69
19,015.06%
-0.02
99.99%
operating cash flow per share
-1.07
-
-1.04
3.07%
-1.78
71.27%
-1.66
6.89%
-1.61
3.09%
-1.70
5.38%
-1.09
35.68%
-1.37
25.82%
-192.56
13,937.06%
-0.02
99.99%
payables turnover
receivables turnover
research and ddevelopement to revenue
320.05
-
12.88
95.97%
15.42
-
11.68
24.21%
return on tangible assets
-0.32
-
-0.24
25.78%
-0.28
18.39%
-0.34
19.92%
-0.51
50.44%
-0.55
8.95%
-0.47
15.35%
-0.48
2.90%
-0.65
35.97%
-0.20
69.51%
revenue per share
0.01
-
0.13
2,095.11%
0.09
-
15.06
17,558.32%
roe
-64.75
-
0.60
100.93%
-0.50
183.12%
-0.85
69.28%
-5.35
529.10%
-3.17
40.84%
-5.11
61.34%
-3.59
29.70%
1.91
153.20%
-0.58
130.30%
roic
-0.71
-
-0.59
16.77%
-0.30
48.88%
-0.45
50.45%
-0.87
90.91%
-0.66
24.12%
-0.70
5.87%
-0.83
19.08%
-0.83
0.25%
-0.06
92.70%
sales general and administrative to revenue
36.85
-
1.72
95.33%
1.81
-
1.77
2.54%
shareholders equity per share
0.02
-
-2.80
13,658.26%
4.26
252.24%
2.23
47.73%
0.35
84.39%
0.59
69.61%
0.21
63.61%
0.28
32.10%
-101.90
36,027.38%
0.03
100.03%
stock based compensation to revenue
-2.17
-
0.05
102.40%
0.27
-
-0.10
137.22%
tangible asset value
3K
-
-9.54M
318,033.33%
28.08M
394.38%
15.21M
45.82%
2.35M
84.53%
4.47M
89.93%
2.02M
54.80%
3.30M
63.22%
-6.79M
305.88%
-15.97M
135.28%
tangible book value per share
0.00
-
-2.82
286,414.44%
4.25
251.02%
2.22
47.79%
0.34
84.53%
0.59
70.93%
0.21
63.93%
0.28
32.80%
-102.25
36,455.68%
-0.13
99.87%
working capital
1.84M
-
-7.10M
485.66%
31.16M
538.85%
17.96M
42.36%
4.02M
77.63%
5.67M
41.22%
2.39M
57.80%
9.03M
277.07%
7.62M
15.61%
-5.73M
175.18%

All numbers in (except ratios and percentages)